ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)2014

A phase I trial of bortezomib and interferon-α-2b in metastatic melanoma.

Joseph Markowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.